Eurofins Scientific/€ERF

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Eurofins Scientific

Eurofins Scientific, with the ticker ERF, is a global bio-analytical testing providing services across several industries including pharmaceutical, food, environmental, and consumer products. Founded in 1987, the company specializes in delivering analytical testing and advisory services to ensure product safety and compliance with regulations. Eurofins operates through a decentralized network of laboratories, serving customers worldwide to enhance health and safety standards.

Ticker

€ERF

Primary listing

PAR

Industry

Life Sciences Tools & Services

Headquarters

Luxembourg City, Luxembourg

Employees

62,696

ISIN

FR0014000MR3

ERF Metrics

BasicAdvanced
€11B
32.58
€1.83
0.81
€1.10
1.01%

What the Analysts think about ERF

Analyst ratings (Buy, Hold, Sell) for Eurofins Scientific stock.

Bulls say / Bears say

Eurofins Scientific reported a 6.87% year-over-year increase in revenue for Q4 2024, indicating strong financial performance. (Google Finance)
The independent audit by Ernst & Young Paris found no material misstatements in Eurofins' cash statements, refuting earlier allegations by short seller Muddy Waters. (Reuters)
Eurofins' net income increased by 17.01% in Q4 2024, reflecting improved profitability. (Google Finance)
Eurofins slightly lowered its revenue forecast for the full year 2024 to nearly 7 billion euros, down from the previous range of 7.075 to 7.175 billion euros. (Reuters)
The company's cash and short-term investments decreased by 49.74% year-over-year in Q4 2024, potentially impacting liquidity. (Google Finance)
Eurofins' net change in cash was negative 33.65 million euros in Q4 2024, indicating cash outflows. (Google Finance)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

ERF Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ERF Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €ERF

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs